...
首页> 外文期刊>Bioorganic and medicinal chemistry >Synthesis of truncated analogues of the iNKT cell agonist, alpha-galactosyl ceramide (KRN7000), and their biological evaluation.
【24h】

Synthesis of truncated analogues of the iNKT cell agonist, alpha-galactosyl ceramide (KRN7000), and their biological evaluation.

机译:iNKT细胞激动剂截短类似物α-半乳糖基神经酰胺(KRN7000)的合成及其生物学评估。

获取原文
获取原文并翻译 | 示例

摘要

Stimulation of iNKT cells by alpha-galactosyl ceramide (alpha-GalCer), also known as KRN7000, and its truncated analogue OCH induces both Th1- and Th2-cytokines, with OCH inducing a Th2-cytokine bias. Skewing of the iNKT cells' response towards either a Th1- or Th2-cytokine profile offers potential therapeutic benefits. The length of both the acyl and the sphingosine chains in alpha-galactosyl ceramides is known to influence the cytokine release profile. We have synthesized analogues of alpha-GalCer with truncated sphingosine chains for biological evaluation, with particular emphasis on the Th1/Th2 distribution. Starting from a common precursor, d-lyxose, the sphingosine derivatives were synthesised via a straightforward Wittig condensation.
机译:α-半乳糖基神经酰胺(α-GalCer)(也称为KRN7000)刺激iNKT细胞,其截短的类似物OCH诱导Th1-Th2细胞因子,OCH诱导Th2-细胞因子偏倚。 iNKT细胞对Th1或Th2细胞因子谱的反应的偏斜提供了潜在的治疗益处。已知α-半乳糖基神经酰胺中酰基和鞘氨醇链的长度都会影响细胞因子的释放曲线。我们已经合成了具有截短的鞘氨醇链的alpha-GalCer类似物,用于生物学评估,尤其着重于Th1 / Th2分布。从常见的前体d-糖开始,通过直接的Wittig缩合反应合成了鞘氨醇衍生物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号